ASND   $148.75  1.47% Market Closed After Close 145.0 -2.52%

Ascendis Pharma A/S
Last Events:

2023-08-09 Signal in Stochastic changed from bullish recovery to bearish reversal. The stochastic indicator is in the upper part of the neutral territory and left the overbought territory. These factors indicate that perhaps the upside trend is coming to an end price will probably head south Last signal: main and signal line crossing.

2023-08-09 Signal in MACD changed from bullish to bullish weakening. Oscillator MACD is in the positive territory it's higher than the signal line and falls. These factors mean that the growing trend persists, but the growth rate is declining. Last signal: signal line crossed the middle level.

2023-08-09 Signal in RSI changed from bullish recovery to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: exit from the overbought zone.

2023-08-09 Signal in EMA100 changed from bullish reversal to bearish reversal. The price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.

2023-08-06 Trend pattern changed from нисходящий треугольник to сужающийся канал.

2023-08-05 Signal in Stochastic changed from bullish weakening to bullish recovery. The stochastic indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: main and signal line crossing.

2023-08-05 Signal in RSI changed from bullish weakening to bullish recovery. RSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: entrance to the overbought zone.

2023-08-05 Signal in EMA100 changed from bearish reversal to bullish reversal. The price is trying to cross up the moving average line If the intersection will be successful, then an upside trend can be formed.


Current temperature: 35.05
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 14
Target Price Mean 195.42
Mean unverified/preliminary 200.00 / 195.42
Target Price Low / High 156.25 / 287.62
Median / STD DEV 194.07 / 29.12
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell None None
rsi Sell Buy None
macd None None None
stoch None None None
ma20 Sell None None
ma50 None None None
ma100 None None None
Candlestick PatternSept. 16, 2024 After Bottom Gap Up - pattern is a made up of five candlesticks. Pattern appears on a downtrend. The pattern begins with a black candlestick. The next two days are also black days. The third day gaps down and opens below the close of the second day. The fifth day is a strong white with a gap above the previous day’s close. Considered to be a bullish reversal pattern.
ISIN US04351P1012
ceo Mr. Jan Moller Mikkelsen
Website https://ascendispharma.com
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.